- The Little Clinic adds new insurance provider to accepted plans
- Gallup: Take Care Clinics top in customer service
- Bartell to cease filling Medicaid prescriptions at 15 locations
- With health reform outlook dimmed, pharmacy can’t abandon its agenda
- More progress needed in health information technology
NEW YORK Wild Child, an Australian-based natural health care products company, began selling in January its Quit Nits head lice products at CVS pharmacies.
Initially, the products are being stocked in the first aid section of the stores and will then be moved to the hair care aisle after the first phase of sales, according to the company.
The Quit Nits product line includes both a treatment cream and a preventative spray made with natural ingredients originating in the Australian outback for those consumers searching for a homeopathic and natural approach to head lice removal.
With a U.S. pharmacy distribution deal, Wild Child hopes to gain a 20 percent share of the $100 million OTC head lice treatment market within its first 12 months of operation. In addition, within the next two years the company will attempt to raise $40 million to $50 million through an initial public offering on the Australian Securities Exchange.